Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)

Summary

This is a multicenter, open-label, one treatment study evaluating the efficacy of LPCN 1021 in adult hypogonadal male subjects.

Timeline

Start

2017-01

Primary completion

2017-05

Completion

2017-07

Drugs

Indications